Practical Neurology
Share
Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.
06/17/2026
Can cell therapy address the compartmentalized that drives progressive ?
Drs. Sarah Conway & Kristin Galetta explore the rationale, early clinical data, and therapeutic potential of CAR T-cell approaches targeting pathogenic B cells and plasma cells in progressive .
https://ow.ly/3Gg850Zcz6Z
Stanford Medicine Harvard Medical School
Qulipta ( ) maintained a favorable safety profile and sustained efficacy through 156 weeks in people with chronic or episodic , according to final phase 3 extension study results presented at 2026.
https://ow.ly/fZ8Q50ZaGWf
American Headache Society® American Academy of Neurology (AAN) AbbVie
Qulipta Maintains Long-Term Safety Profile in 3-Year Migraine Prevention Extension Study KEY TAKEAWAYS Qulipta (atogepant) was generally safe and well tolerated through 156 weeks in people with chronic or episodic migraine. No new safety s…
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
1008 Upper Gulph Road
Wayne, PA
19087
